par 143 par 143 (Hydralazine hydrochloride and hydrochlorothiazide 25 mg / 25 mg)
Pill imprint par 143 par 143 has been identified as Hydralazine hydrochloride and hydrochlorothiazide 25 mg / 25 mg.
Hydralazine/hydrochlorothiazide is used in the treatment of heart failure; high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. Risk cannot be ruled out during pregnancy. Hydralazine/hydrochlorothiazide 25 mg / 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about hydralazine/hydrochlorothiazide
- Other brands: Apresazide
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.